The sphenopalatine ganglion (SPG) has attracted the interest of practitioners treating head and face pain for over a century because of its anatomical connections and role in the trigemino-autonomic reflex. In this review, we discuss the anatomy of the SPG, as well as what is known about its role in the pathophysiology of headache disorders, including cluster headache and migraine. We then address various therapies that target the SPG, including intranasal medication delivery, new SPG blocking catheter devices, neurostimulation, chemical neurolysis, and ablation procedures.
Background: Epidural injections have been used since 1901 in managing low back
pain and sciatica. Spinal pain, disability, health, and economic impact continue to
increase, despite numerous modalities of interventions available in managing chronic
spinal pain. Thus far, systematic reviews performed to assess the efficacy of epidural
injections in managing chronic spinal pain have yielded conflicting results.
Objective: To evaluate and update the clinical utility of the efficacy of epidural
injections in managing chronic spinal pain.
Study Design: A systematic review of randomized controlled trials of epidural
injections in managing chronic spinal pain.
Methods: In this systematic review, randomized trials with a placebo control or
an active-control design were included. The outcome measures were pain relief and
functional status improvement.
The quality of each individual article was assessed by Cochrane review criteria, as well
as the Interventional Pain Management Techniques - Quality Appraisal of Reliability and
Risk of Bias Assessment (IPM-QRB). Best evidence synthesis was conducted based on the
qualitative level of evidence (Level I to V).
Data sources included relevant literature identified through searches of PubMed for a
period starting in 1966 through August 2015; Cochrane reviews; and manual searches
of the bibliographies of known primary and review articles.
Results: A total of 52 trials met inclusion criteria. Meta-analysis was not feasible.
The evidence in managing lumbar disc herniation or radiculitis is Level II for long-term
improvement either with caudal, interlaminar, or transforaminal epidural injections with
no significant difference among the approaches.
The evidence is Level II for long-term management of cervical disc herniation with
interlaminar epidural injections.
The evidence is Level II to III in managing thoracic disc herniation with an interlaminar
approach.
The evidence is Level II for caudal and lumbar interlaminar epidural injections with Level
III evidence for lumbar transforaminal epidural injections for lumbar spinal stenosis.
The evidence is Level II for cervical spinal stenosis management with an interlaminar
approach The evidence is Level II for axial or discogenic pain without facet arthropathy or disc herniation
treated with caudal or lumbar interlaminar injections in the lumbar region; whereas it is Level
II in the cervical region treated with cervical interlaminar epidural injections.
The evidence for post lumbar surgery syndrome is Level II with caudal epidural injections and
for post cervical surgery syndrome it is Level II with cervical interlaminar epidural injections.
Limitations: Even though this is a large systematic review with inclusion of a large number
of randomized controlled trials, the paucity of high quality randomized trials literature
continues to confound the evidence.
Conclusion: This systematic review, with an assessment of the quality of manuscripts and
outcome parameters, shows the efficacy of epidural injections in managing a multitude of
chronic spinal conditions.
Key words: Chronic pain, spinal pain, epidural injections, local anesthetic, steroids,
interlaminar epidural injections, caudal epidural injections, transforaminal epidural injections
Stroke is one of leading causes of mortality and morbidity in the United States. Stroke prevention includes treatment of the stroke risk factors and long-term use of antithrombotic agents. Various agents have been studied for stroke prevention and other trials are ongoing. The aim of this article is to provide an overview of the recent guidelines, recommendations, and clinical trial results using antithrombotic therapy for stroke prevention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.